STIMUFEND
NDC 65219-371, pegflilgrastim-fpgk, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-371
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761173
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-371 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PEGFILGRASTIM6 mg/.6mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Granulocyte-Macrophage Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-371-10 | 65219037110 | 1 BLISTER PACK in 1 CARTON (65219-371-10) / 1 SYRINGE in 1 BLISTER PACK / .6 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b44bcb82-7e60-4dab-a658-115bdf5c053cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65219-371
Use it
Look up 65219-371 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-371 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-371. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.